Drugs / VRC-RSVRGP084-00-VP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03049488 | Feb 2017 → Oct 2019 | respiratory syncytial virus infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VRC-RSVRGP084-00-VP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03049488 ↗ |
| Modality | Vaccine | “VRC-RSVRGP084-00-VP is an investigational respiratory syncytial virus (RSV) vaccine.” NCT03049488 ↗ |